![](/img/cover-not-exists.png)
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy
Lee, Sangmin, Desai, Pinkal, Edirisinghe, Bianca, Pianello, Samantha, Curcio, Tania, Samuel, Michael, Ritchie, Ellen K., Roboz, Gail J.Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1832674
Date:
October, 2020
File:
PDF, 701 KB
2020